| Sep 6 |
Evolus to Ring the Nasdaq Stock Market Closing Bell on Friday, September 13, 2024
|
| Aug 9 |
Evolus, Inc. (EOLS): Is It One of Caligan Partners’ Top Holdings Now?
|
| Aug 2 |
Evolus Continues To Make Progress
|
| Aug 2 |
Evolus Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
| Aug 1 |
Evolus, Inc. (EOLS) Q2 2024 Earnings Call Transcript
|
| Jul 31 |
Evolus, Inc. (EOLS) Reports Q2 Loss, Tops Revenue Estimates
|
| Jul 31 |
Evolus reports mixed Q2 results; updates FY24 outlook
|
| Jul 31 |
Evolus, A Medical Aesthetics Player, Becomes Profitable — Two Quarters Early
|
| Jul 31 |
Evolus Reports Second Quarter 2024 Results and Raises Full Year Revenue Guidance
|
| Jul 31 |
Evolus to Hold Investor Day on September 12, 2024
|
